From a 18 cm x 10 cm surgical wound to closure within 4 days and fully healed by 6 weeks – a typical DermaClose case.
Expand your clinical options
The DermaClose Continuous External Tissue Expander is indicated for use in reducing or assisting with the closure of full-thickness wounds of the skin. DermaClose is the only controlled-force, self-tightening, continuous external tissue expander.
DermaClose improves
DermaClose reduces
Case Reports
Clinical Publications
What your colleagues are saying
“THERE IS NO QUESTION THAT TIME TO CLOSURE, AND THE QUALITY OF THE CLOSURE, IS SUPERIOR WITH THE USE OF DERMACLOSE.”
“MORE RAPID WOUND CLOSURE WITH LESS COMPLEXITY. IT MAKES SENSE.”
“IT INCREASES THE ABILITY TO PERFORM PRIMARY CLOSURE IN CERTAIN CASES, AVOIDS UNNECESSARY SKIN GRAFTS OR ADDITIONAL DONOR SITES IN SELECT CASES, AND CAN IMPROVE OUTCOMES IN A CERTAIN NUMBER OF CASES, WHICH IS INCREDIBLY IMPORTANT.”
DermaClose is the only controlled-force, self-tightening, continuous external tissue expander. It safely and effectively facilitates rapid tissue movement to reduce or re-approximate wounds and is an innovative alternative (or adjunct) to split thickness skin grafts, negative pressure wound therapy, and other complex procedures for achieving primary closure of complex wounds. Once the initial application has been completed, the DermaClose device does not require any additional tightening.
DermaClose gently and rapidly expands the skin on the subcutaneous planes around the wound until the edges are brought close enough together for final suturing and closure. Once set, DermaClose automatically maintains the proper amount of tension and does not need to be readjusted or tightened.
Multiple studies and case reports attest to the efficacy of DermaClose
Albany Medical Center Study
A recent study of 28 patients with fasciotomy wounds found that DermaClose:
- Successfully achieved delayed primary closure in 93% of patients
- Average time to closure 5 days
- No intraoperative or long-term complications were reported
Walter Reed Study
Similarly, a study in 14 blast victims with significant tissue trauma at Walter Reed found that with DermaClose:
- 86% achieved wound closure with delayed primary closure vs 14% who required split thickness skin grafting
- Average time to closure was 4.4 days in wounds averaging 263 cm2
- There were no major complications reported
- The ability to combine DermaClose with negative pressure therapy enabled wound decontamination and closure to be achieved simultaneously
In addition, over 11,500 cases, 20 clinical publications and 30 case studies prove the real world applicability of DermaClose
DermaClose utilizes
skin anchors (made of 316L surgical stainless steel) which are inserted into the skin with the tips approximately 0.5 cm to 1 cm from the edge of the wound. These anchors penetrate 4.5 mm into the subcutaneous tissue and each anchor is then secured with a standard skin stapler. Once the anchors are in place, the line from the DermaClose tension controller is attached around each skin anchor in a shoelace configuration and the knob of the tensioning device is rotated until a clutch mechanism provides an audible indication that full tension has been achieved. It is a sterile, single patient use device. A 3M skin stapler is included with the kit. The tension controller is just 1.7 inches wide, 2.6 inches long, 0.8 inches high and is made of ABS plastic. The nylon suture loop is 66 cm long. Typically one DermaClose is used per each 10 cm of length of the wound. For wounds that are 10 cm or more wide it is recommended to use one DermaClose XL per 10 cm of length. Multiple devices can be used for large wounds. The new DermaClose XL device comes with a 95cm loop of line.
Typically DermaClose will reapproximate wound edges within 2 to 7 days. Once the wound edges are within 1 cm definitive closure can be performed. This can be accomplished by removing the device and suturing or stapling the wound edges together.
The DermaClose Continuous External Tissue Expander is indicated for use in reducing or assisting with the closure of full-thickness wounds of the skin.
The DermaClose Continuous External Tissue Expander should not be used on ischemic or infected tissue. It should not be used on fragile tissue at the edges of a wound.
Find your sales representative
[ninja_tables id=”3980″]
